Algae.Tec opens new facility in Australia
Australia | News | By BioSpectrum Bureau | 0 Comment | 16 Aug, 2012
Singapore: Algae.Tec, an advanced algae to biofuels company, has opened a new facility Shoalhaven One at Nowra, south of...Read more
Australia | News | By BioSpectrum Bureau | 0 Comment | 06 Oct, 2014
Singapore: Australia-based Prima BioMed has announced the acquisition of France-based Immutep, a private biopharmaceutic...Read more
APAC colorectal cancer market to touch $2.9 bn by 2020
Australia | Analysis | By BioSpectrum Bureau | 0 Comment | 18 Dec, 2014
Singapore: Colorectal Cancer (CRC) therapeutics market in Asia-Pacific (APAC) is set to increase in value, from $1.9 bil...Read more
Patrys gets nod to continue myeloma trial
Australia | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2013
Singapore: Patrys received approval to progress its phase I/IIa PAT-SM6 multiple myeloma trial based on safety data from...Read more
Riverside to invest $100mn in Australia's health
Australia | News | By BioSpectrum Bureau | 0 Comment | 11 Aug, 2014
Singapore: The global private equity firm, Riverside Company has said that it would be investing about $100 million in A...Read more
Samsung Australia's MedTech unit opens
Australia | News | By BioSpectrum Bureau | 0 Comment | 12 Sep, 2014
Singapore: A new health and medical equipment division has been launched by global technology giant, Samsung, in Austral...Read more
Cytomedix plasma preparation device gets TGA nod
Australia | Regulatory | By BioSpectrum Bureau | 0 Comment | 12 Feb, 2013
Singapore: Cytomedix's Angel cPRP System has been listed by the TGA (Therapeutic Goods Administration) in Australia. Fo...Read more
NIH places GSC's 25 stem cell lines on its registry
Australia | News | By BioSpectrum Bureau | 0 Comment | 15 Jan, 2013
Singapore: Genea Stem Cells (GSC), a supplier and developer of disease-specific human stem cells, announced that 25 of ...Read more
OccuRx kick starts with $5.21 mn investment
Australia | News | By BioSpectrum Bureau | 0 Comment | 18 May, 2015
Singapore: OccuRx, an Australian biopharmaceutical company developing a new class of drugs to prevent health burden due ...Read more
APAC Non-Hodgkin Lymphoma treatment market to touch $1.7 bn'
Australia | Analysis | By BioSpectrum Bureau | 0 Comment | 26 Sep, 2014
Singapore: Non-Hodgkin Lymphoma (NHL) treatment market in Asia-Pacific (APAC) countries including India, Australia, Chin...Read more
CSL to buy Novartis' influenza vaccine unit
Australia | News | By BioSpectrum Bureau | 0 Comment | 27 Oct, 2014
Singapore: Novartis has agreed to sell its influenza vaccines business to Australia's CSL, a blood products and vaccines...Read more
Researchers discover antibody to prevent dengue
Australia | News | By BioSpectrum Bureau | 0 Comment | 31 Dec, 2014
Singapore: A group of international researchers, including from University of Melbourne, have discovered a new class of ...Read more
Prana drug reduces cognitive impairment
Australia | News | By BioSpectrum Bureau | 0 Comment | 05 Mar, 2013
Singapore: Prana Biotechnology announced the upcoming presentation of new data demonstrating the ability of PBT2 to redu...Read more
Aussie firm's new breakthrough in bladder cancer
Australia | News | By BioSpectrum Bureau | 0 Comment | 10 Jan, 2015
Singapore: Australia-based startup company Sienna Cancer Diagnostics, has inked a pact with an American pathology compan...Read more
Brain cancer drug may be effective in melanoma treatment
Australia | News | By BioSpectrum Bureau | 0 Comment | 17 Dec, 2014
Singapore: Australia based Novogen's lead candidate, TRXE-009, developed for the treatment of brain cancers, has shown t...Read more
Australia to review kids' asthma drugs
Australia | Regulatory | By BioSpectrum Bureau | 0 Comment | 20 Feb, 2013
Singapore: Department of Health and Ageing under the Australian Government's National Medicines Policy framework, is con...Read more
Aus minister launches code book for directors
Australia | News | By BioSpectrum Bureau | 0 Comment | 29 Oct, 2013
Singapore: Australia's Minister for Technology, Mr Gordon Rich-Phillips launched the two-day Australia Biotech Invest 20...Read more
Aussie firm initiates bronchitis drug trial for smokers
Australia | News | By BioSpectrum Bureau | 0 Comment | 23 Jul, 2013
Singapore: Australia-based clinical-stage drug development company, Invion, initiated and commenced patient enrolment in...Read more